Dorsey Wright & Associates Standard Biotools Inc. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$4.63 - $12.15 $5,972 - $15,673	-1,290 Closed	0 $0
Q2 2019 Jul 02, 2019	BUY	$11.49 - $14.17 $3,699 - $4,562	322 Added 33.26%	1,290 $16,000
Q1 2019 Apr 04, 2019	SELL	$8.47 - $14.36 $8,182 - $13,871	-966 Reduced 49.95%	968 $13,000
Q4 2018 Jan 07, 2019	BUY	$7.18 - $8.83 $13,886 - $17,077	1,934 New	1,934 $17,000

146

265M

356K

400

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $156M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.